Centre for Evidence-based Medicine,
https://www.nejm.org/doi/full/10.1056/NEJMoa2108269?query=TOC
https://www.nejm.org/doi/full/10.1056/NEJMoa2108269?query=TOC
Cardiovascular and #RenalOutcomes with #Efpeglenatide in Type 2 Diabetes @NEJM http://ow.ly/mjV150G2HVB
trial involving participants with type 2 diabetes who had either a history of cardiovascular disease or current kidney disease…
https://www.nejm.org/doi/full/10.1056/NEJMoa2108269?query=TOC